JAMP PHARMA CORPORATION — Apixaban Importer Profile
Pharmaceutical Importer · #12 buyer for Apixaban · $2.4M import value · 87 shipments · CANADA · DGFT Verified
JAMP PHARMA CORPORATION is the #12 importer of Apixaban from India with $2.4M in import value and 87 verified shipments. JAMP PHARMA CORPORATION holds a 1.3% market share in Apixaban imports based in CANADA. The company sources from 1 verified supplier across 62 formulations shipped to 1 country. Overall, JAMP PHARMA CORPORATION imports 14 pharmaceutical products worth $13.3M across 9 therapeutic categories.
JAMP PHARMA CORPORATION — Apixaban Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Apixaban to JAMP PHARMA CORPORATION?
Verified from 87 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| UNISON PHARMACEUTICALS PRIVATE LIMITED | $2.4M | 87 | 100.0% |
JAMP PHARMA CORPORATION sources Apixaban from 1 verified Indian supplier based on 87 customs records. The primary supplier is UNISON PHARMACEUTICALS PRIVATE LIMITED accounting for 100.0% of imports.
How Does JAMP PHARMA CORPORATION Compare to Nearest Apixaban Importers?
Buyers ranked immediately above and below #12 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | EXPRESS TRAILERS LTD. | MALTA | $3.2M | 64 | $50.0K |
| 10 | SANDOZ B.V. | NETHERLANDS | $2.6M | 72 | $35.6K |
| 12 | JAMP PHARMA CORPORATION ★ | CANADA | $2.3M | 71 | $32.7K |
| 8 | APOTEX INC,-4100 WESTON ROAD | CANADA | $2.3M | 46 | $50.0K |
| 13 | APOTEX INC. -4100 WESTON ROAD | CANADA | $2.2M | 50 | $43.6K |
JAMP PHARMA CORPORATION ranks #12 among 371 Apixaban importers from India. Average shipment value of $32.7K compared to the market average of $125.9K. The closest competitors by value are EXPRESS TRAILERS LTD. and SANDOZ B.V..
Where Does JAMP PHARMA CORPORATION Import Apixaban To?
Destination countries from 87 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $2.4M | 87 | 100.0% |
JAMP PHARMA CORPORATION imports Apixaban to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $2.4M.
What Apixaban Formulations Does JAMP PHARMA CORPORATION Import?
| Formulation | Value | Shipments |
|---|---|---|
| JAMP APIXABAN TABLETS 5 MG(1X500T)BT(API | $150.0K | 3 |
| JAMP APIXABAN TABLETS 5 MG(6X10T)BL (APIXABAN)(1 NOS=1PACK)B.NO.:2430059,2430060,2430061 | $143.0K | 3 |
| AG-APIXABAN TABLETS 5 MG 1 X 500T BT | $98.5K | 3 |
| JAMP APIXABAN TABLETS 5 MG(1X180T)BT (AP | $93.4K | 2 |
| JAMP APIXABAN TABLETS 5 MG (1X500T) BT ( | $87.8K | 2 |
| JAMP APIXABAN TABLETS 5 MG (1X180T) BT ( | $87.3K | 2 |
| JAMP APIXABAN TABLETS 5 MG 1 X 180T B | $86.3K | 3 |
| JAMP APIXABAN TABLETS 5 MG(1X60T)BT(APIX | $76.1K | 2 |
| JAMP APIXABAN TABLETS 2.5 MG(6X10T)BL(APIXABAN)(1NOS=1PACKS)B.NO.2430056,2430057,2430058 | $68.7K | 3 |
| JAMP APIXABAN TABLETS 2.5 MG(1X500T)BT(A | $67.4K | 2 |
JAMP PHARMA CORPORATION imports 62 distinct Apixaban formulations from India. The top formulation is JAMP APIXABAN TABLETS 5 MG(1X500T)BT(API with 3 shipments worth $150.0K.
Regulatory Requirements: Importing Apixaban into Canada
What JAMP PHARMA CORPORATION and other importers must comply with to import Apixaban from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Apixaban
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Apixaban from India and How Much Does JAMP PHARMA CORPORATION Import?
India exported $46.7M worth of Apixaban through 4,492 shipments from 171 suppliers to 98 countries, serving 371 buyers globally. JAMP PHARMA CORPORATION imports $2.4M of this total, accounting for 1.3% of India's Apixaban exports with 87 shipments from CANADA. This is verified from 87 customs shipment records covering 62 distinct formulations.
What Is the Average Order Value for JAMP PHARMA CORPORATION's Apixaban Imports?
JAMP PHARMA CORPORATION's average Apixaban order value is $27.9K per consignment, based on 87 shipments totaling $2.4M. JAMP PHARMA CORPORATION is based in CANADA and ranks #12 among all Apixaban importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Apixaban to JAMP PHARMA CORPORATION?
JAMP PHARMA CORPORATION sources Apixaban from 1 verified Indian supplier: UNISON PHARMACEUTICALS PRIVATE LIMITED ($2.4M, 100.0%). This is based on 87 customs records.
How Does JAMP PHARMA CORPORATION Compare to Other Apixaban Importers?
JAMP PHARMA CORPORATION ranks #12 among 371 Apixaban importers from India with a 1.3% market share. The top 3 importers are MYLAN IRELAND LIMITED ($6.3M), APOTEX INC, ($6.2M), APOTEX INC ($5.8M). JAMP PHARMA CORPORATION processed 87 shipments from CANADA.
What Other Cardiovascular Products Does JAMP PHARMA CORPORATION Import?
JAMP PHARMA CORPORATION also imports these cardiovascular products. Each links to the detailed product page.
About JAMP PHARMA CORPORATION
JAMP PHARMA CORPORATION imports 14 products worth $13.3M. Beyond Apixaban, top products include Dapagliflozin, Acyclovir, Valacyclovir, Bisoprolol, Natural. View the complete JAMP PHARMA CORPORATION profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Apixaban — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Apixaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: JAMP PHARMA CORPORATION matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as JAMP PHARMA CORPORATION's capped import value divided by total capped export value for Apixaban across all Indian exporters.
- 5.Verified Records: This page is backed by 87 individual customs records matching JAMP PHARMA CORPORATION importing Apixaban, covering 62 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 98+ countries, 371+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Apixaban Import Data for JAMP PHARMA CORPORATION
Access order-level details, pricing data, supplier connections, and competitive analysis for JAMP PHARMA CORPORATION's Apixaban imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
JAMP PHARMA CORPORATION
Full Company Profile →
14 products · $13.3M total trade · 9 categories
JAMP PHARMA CORPORATION × Apixaban
Verified from customs records
Company Overview
Top Products by JAMP PHARMA CORPORATION
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for JAMP PHARMA CORPORATION.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Apixaban. For current order-level data, contact TransData Nexus.